Ambros Therapeutics launches with $125M to advance neridronate, a non-opioid therapy for CRPS-1. See how this Phase 3-ready ...

Bisphosphonates reduced complex regional pain syndrome pain intensity in the short term but not other time scales.

Some people may be genetically predisposed to develop the rare, disabling disorder complex regional pain syndrome type 1 (CRPS-1), according to a new study led by the University of Cambridge. The ...

Abiogen Pharma is a recognized leader in the discovery and development of bisphosphonates including the advancement of neridronate. Neridronate was approved in Italy based on the safety and efficacy ...

Genes may be responsible for third of complex regional pain syndrome cases. But the condition is less common in men, even though they are more likely to have the 4 genetic variations implicated in ...

Discover the CRPS certification, its role in retirement planning for businesses, exam details, benefits, and ongoing ...

CRPS typically develops in a limb after injury or surgery and can lead to long-term disability. It causes severe, persistent pain that is often far worse than the initial injury, along with swelling ...

Taneia Surles is health and wellness writer and public health professional that has been creating health and wellness content since 2020. Her writing has covered several verticals, including sexual ...

“It’s all sorts of different pain I never knew was possible,” said Bella Macey, 10, who was diagnosed with a rare and painful condition called complex regional pain syndrome GoFundMe An Australian ...

Complex regional pain syndrome, or CRPS, is a rare, difficult to diagnose condition at the center of the recent $261 million verdict against Johns Hopkins All Children’s Hospital. A jury on Nov. 9 ...

Complex Regional Pain Syndrome (CRPS) is a chronic and debilitating pain disorder, typically considered lifelong with limited treatment options. Now, groundbreaking research finds that early detection ...